Abstract:Human T-cell lymph tropic virus type 1 (HTLV-1) is a retrovirus that is transmitted during sexual intercourse, contact with infected blood and tissues, and from mother to child. It is clear that some countries have a higher prevalence of HTLV-1 infection based on population size. [ 1 ] There are foci in South America, especially in parts of Colombia and French Guyana, some areas of intertropical Africa, and in the Middle East (such as the Mashhad region in Iran), and rarely isolated clusters in Australia and Melanesia. [ 2 ] This infection can lead to a diverse clinical picture and tends to become chronic. [ 3 ] Overall, 3%–5% of people infected with HTLV-1 develop tropical spastic paraparesis (TSP) (HTLV-I-associated myelopathy [HAM]/TSP) (HTLV-I-related myelopathy/TSP) in the fourth decade of life. [ 4 ] HAM/TSP is a chronic, degenerative, and progressive inflammatory process that affects the spinal cord, and causes demyelination and decreased sensory capacity. [ 5 ] The most common symptoms of lower extremity muscle weakness are hyperreflexia, hypertension, pelvic floor dysfunction, and moderate-to-severe pain. [ 6 ] To be able to continue long-term or lifelong treatments, it is necessary to start treatment approaches as soon as possible, safely, and at a low cost. [ 7 ] Nonpharmacological methods may play an important role in the management of symptoms in people. Over the past few years, the use of nonpharmacological methods to manage the problems and physical symptoms of these patients has been considered and several articles have examined the effects of such interventions. [ 5 ] However, there is little evidence of the effectiveness of nonpharmacological approaches in patients with this disease. [ 7 ] Therefore, the current systematic review has two key objectives: first, to identify nonpharmacological approaches that can be used in these patients, and second, to identify the results of applying these approaches to patients.

Nonpharmacological interventions and outcomes in the management of complications of human T-cell lymphotropic virus type 1-related myelopathy/tropical spastic paraparesis: A systematic review

HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): Case based discussion of risk factors, clinical, and therapeutic considerations

Mycophenolate mofetil for the long-term treatment of HTLV-1 associated myelopathy: A case report

Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients

Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis

Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection

Current State of Therapeutics for HTLV-1

Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies

Mapping variants in HTLV-1 genome to analyze their impacts on the HAM/TSP development: A systematic review

Role of Integrin Signaling Activation on the Development of Human T Cell Leukemia Virus-1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis: Its Relationship to HTLV-1-Infected CD4+ T Cell Transmigrating Activity into the Tissues

Novel approaches for HTLV-1 therapy: innovative applications of CRISPR-Cas9

Non-cancerous complications in HTLV-1 carriers

HTLV-1-associated myelopathy in Spain

How Can We Prevent Mother-to-Child Transmission of HTLV-1?

Multistability in a Model for CTL Response to HTLV-I Infection and Its Implications to HAM/TSP Development and Prevention

B-cell depletion limits HTLV-1-infected T-cell expansion and ameliorate HTLV-1-associated myelopathy

Stem Cell Therapy for HTLV-1 Induced Adult T-Cell Leukemia/Lymphoma (ATLL): A Comprehensive Review

How do socioeconomic determinants of health affect the likelihood of living with HTLV-1 globally? A systematic review with meta-analysis

Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy

Analysis of Clinical Characteristics and Prognosis of Talaromycosis (with or Without Human Immunodeficiency Virus) from a Non-Endemic Area: a Retrospective Study

Human T cell lymphotropic virus type 1 in Zimbabwe